FDA DEVICE FACTS
VERSANT HCV GENOTYPE 2.0 ASSAY (LiPA)
Fujirebio Europe N.V.
Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。
Indications for use
The genotyping device for hepatitis C virus (LiPA) consists of the following 4 separate kits:
• VERSANT® HCV Genotype 2.0 Assay (LiPA)
• VERSANT® Sample Preparation 1.0 Reagents
• VERSANT® HCV Amplification 2.0 Kit (LiPA)
• VERSANT® HCV Control 2.0 Kit (LiPA) VERSANT® HCV Genotype 2.0 Assay (LiPA) The VERSANT® HCV Genotype 2.0 Assay (LiPA) is a line probe assay, for in vitro diagnostic use, which identifies Hepatitis C virus (HCV) genotypes 1 to 6 and subtypes 1a and 1b in human serum or plasma (K2-EDTA, ACD-A CPD, and CPDA) samples. The VERSANT® HCV Genotype 2.0 Assay (LiPA) is intended to be used as an aid in the management of patients with chronic HCV infection to guide the selection of antiviral treatment. The VERSANT® HCV Genotype 2.0 Assay (LiPA) is not approved for use as a donor screening test for HCV or as a diagnostic test to confirm the presence of HCV.
VERSANT® Sample Preparation 1.0 Reagents The VERSANT® Sample Preparation 1.0 Reagents kit is intended to be used, along with the VERSANT® kPCR Molecular System Sample Preparation module (SP Module), for the isolation and purification of nucleic acids for in vitro diagnostic
applications. The product is intended for use by laboratory professionals trained in molecular biology techniques.
VERSANT® HCV Amplification 2.0 Kit (LiPA) The VERSANT® HCV Amplification 2.0 Kit (LiPA) is designed for use with the VERSANT® HCV Genotype 2.0 Assay (LiPA) and the VERSANT® HCV Control 2.0 Kit (LiPA) products. The HCV Amplification 2.0 kit is for in vitro diagnostic use for reverse transcription and amplification of the 5' untranslated region (5'UTR) and core region of the Hepatitis C Virus (HCV) genome.
VERSANT® Control 2.0 Kit (LiPA) The VERSANT® HCV Control 2.0 Kit (LiPA) is designed for use with the VERSANT® HCV Amplification 2.0 Kit (LiPA) and the VERSANT® HCV Genotype 2.0 Assay (LiPA) products. The VERSANT® HCV Control 2.0 Kit (LiPA) is for in vitro diagnostic use to monitor the performance of all steps of the VERSANT® HCV Genotype 2.0 assay.
All four kits are required to extract nucleic acids from patient samples, serve as external controls, amplify specific regions of the HCV sequence, hybridize the amplified material to probes and identify the HCV genotype.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。